Aduro Biotech Announces Initiation of Phase 1b Clinical Trial in Non-Small Cell Lung Cancer under Janssen Strategic Partnership Biotech Investing
Fortive Announces Binding Offer to Acquire the Advanced Sterilization Products Business from Johnson & Johnson Pharmaceutical Investing
Cellectar Granted U.S. Patent for the Treatment of Various Cancers and Cancer Stem Cells with CLR 131 Pharmaceutical Investing
K2M Surpasses 100th Product Milestone with FDA Clearance and Launch of OZARK Cervical Plate Systems Medical Device Investing
Biogen Enters Exclusive Option Agreement to Acquire TMS’ Phase 2 Asset for Acute Stroke Pharmaceutical Investing
